• Title/Summary/Keyword: Lens Shielding Device

Search Result 5, Processing Time 0.016 seconds

The Use of Lens Shielding Device(L.S.D.) for a Conjunctival Lymphoma

  • Cho Hyun Sang;Ju Sang Gyu;Song Ki Won;Park Young Hwan
    • The Journal of Korean Society for Radiation Therapy
    • /
    • v.9 no.1
    • /
    • pp.40-45
    • /
    • 1997
  • When therapeutic irradiation is indicated for the orbital tumors, the greatest concern is the risk of radiation-induced cataract. Conjunctival lymphoma is one of the good examples. We would like to report the procedure of the lens shielding device(L.S.D) and the result of irradiated dose to the lens. L.S.D. consistes of two parts : load alloy to attenuate electron beam, and dental acryl which completely covers the lead alloy to avoid discomfort of cornea from contacting directly with cerrobend and side scattering by cerrobend. And for easy location and removal, side bars were made on each side. Radiation doses were meaured with TLD(TLD 3500 Hawshaw). Markus chamber in a polystyrene phantom. The phantom was irradiated with 9MeV electron beams from Clinac 2100C with $6{\times}6cm$ electron cone. The relative dose at 6mm depth where the lens is located was $4.2\%$ with TLD and $5.1\%$ with Markus chamber clinically when 2600 cGy are irradiated to the eyeball, the mapinary dose to the lens will be 109 cGy or 132 cGy, which will significently reduce the cataract.

  • PDF

Efficacy of Lens Shielding Device to Prevent Cataract with Radiotherapy for Orbit or Ocular Adnexal Tumor (안와 및 안부속기 종양의 방사선치료에서 백내장의 예방을 위한 렌즈보호 장치의 효용성)

  • Cho, Jung-Keun;Cho, Hyun-Sang;Han, Tae-Jong
    • The Journal of the Korea Contents Association
    • /
    • v.7 no.12
    • /
    • pp.139-144
    • /
    • 2007
  • Radiotherapy which is the most effective for orbit lymphoma has been used increasingly due to the increase of orbit or ocular adnexal tumor patients. Curative effects and convalescence have been being more satisfied thanks to remarkable development of cancer chemotherapy and medical treatments, but side effects such as cataract, dry eye and retinopathy still break out. Thus, in this study, a Lens Shielding Device (LSD hereafter) was designed to prevent occurring of cataract due to radiation therapy for orbit lymphoma and its efficacy through dosimetry were evaluated. And in this paper, its manufacturing process was also explained. LSD is composed of a cover body covering the lens and a side fixing part supporting the cover body. To measure radiation, the patient therapy conditions were simulated and the measurement of the radiation was conducted with Thermo Luminescence Detector (TLD) and Markus chamber. The average TLD value was 5.7% and the TLD value and Markus chamber value were acquired as 4.2% and 5.1% respectively at 6 mm depth where zero lens center was located. Only 1.5Gy ($300Gy{\times}\;5%$) or 5% of total 30Gy with 9 MeV electron beam is estimated to affect on patient's lens. That is smaller dose than the threshold value of cataract (2GY) or the value (5Gy) that was reported to cause cataract in clinical conditions. Thus, these findings suggest that LSD be very useful for prevention of cataract during radiotherapy for malignant lymphoma of orbit and ocular adnexa. Furthermore, it might be possible to reduce patient's discomfort caused by alien substances and to make it easier to fix the device with customized manufacturing manners.

Development of Patient-Immobilizing Device for Total Body Irradiation (TBI) (전신 방사선치료(Total Body Irradiation, TBI)를 위한 한국인에 맞는 환자 고정장치에 관한 연구)

  • 김명세
    • Progress in Medical Physics
    • /
    • v.13 no.3
    • /
    • pp.114-119
    • /
    • 2002
  • A immobilizing device that is essential for correct lung and lens shielding with homogenous dose distribution in fractionated total body irradiation was developed and it's efficiency was evaluated. The main frame was made of stainless steel bar (5 cm in diameter) to withstand up to 230 cm in height and 100 kg in weight to prevent any injury even in unconsciousness condition. The saddle was designed to adjust the body weight and hight of standing patients. Chest and back supporter were made of 1 cm acryl which could fix the lung block and cassette holder. Leather and sponge pedding were used for head rest to keep patients comfortable. The device was strongly fixed by specially designed bolts on the bottom panel which was made of 1 cm stainless steel and 10 cm thick wooden board. Precise manipulation ($\pm$2 mm) was possible by upper two pulleys and side handles. Average four minutes twenty five seconds were needed for exact setting in fractionated TBI. No significant difference of lung block location on repeated verification films was confirmed and relatively homogeneous dose distribution was measured in rando phantom experiments and patient treatments ($\pm$5%). This immobilizing device was very efficient to keep correct position of patients, which is essential for better result and less complication in fractionated TBI.

  • PDF

Measurement dose of Dental Panoramagraphy using a Radiophotoluminescent Glass Rod Detector (유리선량계를 이용한 파노라마 검사의 피폭선량 측정)

  • Kim, Chang-Gyu
    • Journal of the Korea Academia-Industrial cooperation Society
    • /
    • v.12 no.6
    • /
    • pp.2624-2628
    • /
    • 2011
  • Exposed dose of a patient was measured by Radiophotoluminescent Glass Rod Detector with a use of a panorama graphic device in dental examination. The effect of exposed dose in optic lens was measured by comparing the different materials of the glasses. Depending on the dental location, the exposed dose distribution was 82.4~2,340uSv. It showed that the maximum difference in dose distribution was over 300%. Thus, when manufacturing the devices, it seemed to require shortening the pre-heat time and additional shielding in order to control the diagnosis and exposed dose. The measurement data of the exposed dose in optic lens was increased 20~75uSv per each test when compared putting on glasses with not wearing. As a result, taking off the glasses is recommended to improve efficiency of the test and minimize the exposed dose during dental panorama graphic examinations.